Book a Meeting

Anti-Interleukin 31 Antibody, Non-Fucosylated (BioBet-1092ZP) (CAT#: BioBet-1092ZP) Datasheet

Target
Interleukin 31
Isotype
IgG
Description
Anti-Interleukin 31 Antibody, Non-Fucosylated (BioBet-1092ZP) is a humanized monoclonal IgG antibody against Interleukin 31. This product is an ADCC enhanced antibody produced by our Afuco™ platform.
Antibody Indication
Atopic Dermatitis
Classification
Therapeutic antibody; biobetter

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Interleukin 31 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
IL31
Full Name
interleukin 31
Background
IL31, which is made principally by activated Th2-type T cells, interacts with a heterodimeric receptor consisting of IL31RA (MIM 609510) and OSMR (MIM 601743) that is constitutively expressed on epithelial cells and keratinocytes. IL31 may be involved in the promotion of allergic skin disorders and in regulating other allergic diseases, such as asthma (Dillon et al., 2004 ).
Alternative Names
IL31; interleukin 31; IL-31; interleukin-31
Gene ID
386653
Cellular Localization
Extracellular region or secreted
Involvement in Disease
Diseases associated with IL31 include Allergic Contact Dermatitis and Contact Dermatitis.
Related Pathways
Its related pathways are PEDF Induced Signaling and Innate Immune System.
Function
The IL31 heterodimer receptor composed of IL31RA and OSMR activates STAT3, possibly STAT1 and STAT5. May have an effect on skin immunity. Improve the survival rate of bone marrow progenitor cells in vitro (through similarity). Induce the expression of RETNLA and serum amyloid A in macrophages (by similarity).
Post-translational modifications
Glycosylation at Asn67 and Asn100
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG
Antibody Clone
BioBet-1092ZP
Host
Humanized
Species Reactivity
Human
Description
This is an anti-IL31 monoclonal antibody used as a potential treatment for atopic dermatitis, as well as for other diseases.
Antibody Indication
Atopic Dermatitis

Atopic Dermatitis

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.